Pierre Fabre case law refers to a landmark legal ruling in the European Union that established the principle of free competition in the pharmaceutical industry. This case, brought by the French pharmaceutical company Pierre Fabre, challenged the restrictions placed on the online sale of their products by their authorized distributors. The ruling, delivered by the European Court of Justice in 2011, declared that such restrictions were in violation of EU competition law and set a precedent for future cases involving online sales and distribution of goods. The Pierre Fabre case law has had a significant impact on the pharmaceutical industry, promoting fair competition and consumer choice in the digital marketplace.